Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000488282 | SCV000251087 | likely benign | not provided | 2021-09-20 | criteria provided, single submitter | clinical testing | Reported in heterozygous state in the published literature in an individual with infantile onset lactic acidosis and hypertrophic cardiomyopathy, however this individual's unaffected mother was also heterozygous for this variant (Vasta et al., 2012) In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect This variant is associated with the following publications: (PMID: 22494076, 27165006) |
Illumina Laboratory Services, |
RCV000369996 | SCV000407639 | benign | Spinocerebellar ataxia type 28 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Ce |
RCV000488282 | SCV000575130 | uncertain significance | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000488282 | SCV000802467 | uncertain significance | not provided | 2021-06-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000488282 | SCV001101683 | likely benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001262989 | SCV001441055 | uncertain significance | Spastic ataxia 5 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000488282 | SCV001474594 | uncertain significance | not provided | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000197194 | SCV001880330 | benign | not specified | 2020-11-10 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV000369996 | SCV005900393 | likely benign | Spinocerebellar ataxia type 28 | 2024-06-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004755808 | SCV005344569 | likely benign | AFG3L2-related disorder | 2024-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |